Verona Pharma PLC (VRNA)
15.47
+0.16
(+1.05%)
USD |
NASDAQ |
Apr 26, 16:00
15.50
+0.03
(+0.19%)
After-Hours: 20:00
Verona Pharma Cash from Operations (TTM): -50.22M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -50.22M |
September 30, 2023 | -47.56M |
June 30, 2023 | -52.93M |
March 31, 2023 | -51.13M |
December 31, 2022 | -59.86M |
September 30, 2022 | -69.45M |
June 30, 2022 | -28.53M |
March 31, 2022 | -29.22M |
December 31, 2021 | -33.25M |
September 30, 2021 | -34.73M |
June 30, 2021 | -67.55M |
March 31, 2021 | -50.40M |
December 31, 2020 | -45.08M |
Date | Value |
---|---|
September 30, 2020 | -37.83M |
June 30, 2020 | -36.24M |
March 31, 2020 | -43.23M |
December 31, 2019 | -42.87M |
September 30, 2019 | -37.29M |
June 30, 2019 | -29.76M |
March 31, 2019 | -27.11M |
December 31, 2018 | -22.98M |
September 30, 2018 | -23.83M |
June 30, 2018 | -33.50M |
March 31, 2018 | -32.30M |
December 31, 2017 | -27.97M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-69.45M
Minimum
Sep 2022
-28.53M
Maximum
Jun 2022
-44.58M
Average
-43.23M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
NuCana PLC | -32.90M |
TC BioPharm (Holdings) PLC | -13.16M |
Biodexa Pharmaceuticals Plc | -8.515M |
Adaptimmune Therapeutics PLC | -140.88M |
Bicycle Therapeutics PLC | -60.63M |